FDA required human cell, tissue and cellular and tissue-based product establisments to screen and test cell and tissue donors for risk factors for relevant communicable diseases (21 C.F.R. Parts 210, 211, 820 and 1271). Effective date: May 25, 2005.
FDA required human cell, tissue and cellular and tissue-based product establisments to screen and test cell and tissue donors for risk factors for relevant communicable diseases (21 C.F.R. Parts 210, 211, 820 and 1271). Effective date: May 25, 2005.
Action
Published Date
Agency
Code CFR
21 C.F.R. Parts 210, 211, 820 and 1271
Department
Pages
29785-29835
Volume Number
69
